Bio
Dr. Nishiga is an Instructor at the Stanford Cardiovascular Institute. As a physician-scientist, he focuses on unraveling the mechanisms of cardiovascular diseases and developing innovative treatments. His research path was sparked by firsthand experiences with heart failure patients during his clinical practice, where he recognized the urgent need for more effective treatments. After completing his cardiology fellowship in Japan, he pursued a Ph.D. at Kyoto University, focusing on the role of microRNAs and non-coding RNAs in heart failure, cardiac fibrosis, and atherosclerosis. Currently at Stanford and under the guidance of Dr. Joseph Wu, Dr. Nishiga's postdoctoral research leverages iPSCs and CRISPR technology. His primary research areas include the cardiac impacts of cancer therapies, the cardiovascular effects of COVID-19, and the influence of marijuana use on vascular inflammation.
